According to a study published in the Journal of Clinical Investigation today*.

Significantly, lower activity in these genes was also linked to poorer survival in sufferers with a number of different cancers. This suggests that adding AKT inhibitors to radiotherapy could possibly be an effective method to treat many cancers. Study leader Dr. Ester Hammond, a Cancer Research UK scientist at the University of Oxford, stated, 'this exciting discovery sheds light on the part of oxygen starvation in cancer advancement and shows that drugs already getting trialled in cancer patients could potentially raise the effectiveness of radiotherapy across a variety of cancers. We hope that this important little bit of the jigsaw shall support ongoing efforts to develop medications that enhance radiotherapy, so that a lot more patients can benefit from this cornerstone of malignancy treatment.' Eleanor Barrie, Malignancy Research UK's senior science information manager, said, 'developments in how we provide radiotherapy and utilize it in conjunction with other treatments have the potential to improve survival for thousands of cancer patients.Methods Data Study and Sources Population We analyzed all Medicare Service provider Evaluation and Review medical center claims from 1992 through 2005 to identify beneficiaries 65 years of age or older for whom a claim for payment had been made for in-hospital CPR, thought as the current presence of either of the next two method codes in the International Classification of Diseases, Ninth Revision : 99.60 or 99.63 . We restricted analyses to sufferers who received Medicare through the Old-Age group and Survivors Insurance system and excluded those who received Social Security Disability Income.